Can we predict the severity of coronavirus disease 2019 with a routine blood test?
- 29 May 2020
- journal article
- research article
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 130 (5), 400-406
- https://doi.org/10.20452/pamw.15331
Abstract
INTRODUCTION The ongoing worldwide pandemic of coronavirus disease 2019 (COVID-19) has posed a huge threat to global public health. However, the issue as to whether routine blood tests could be used to monitor and predict the severity and prognosis of COVID-19 has not been comprehensively investigated so far. OBJECTIVES This study aimed to provide an overview of the association of markers in the routine blood test with the severity of COVID-19. METHODS PubMed, Embase, Cochrane Library, Wanfang, and China National Knowledge Infrastructure (CNKI) databases were searched to identify studies reporting data on markers in the routine blood test and the severity of COVID-19, published until March 20, 2020. The STATA software was used for meta-analysis. RESULTS A total of 15 studies with 3090 patients with COVID-19 were included in this analysis. Patients in the nonsevere group, compared with those in the severe group, had lower counts of white blood cells (weighted mean difference [WMD], -0.85 [ x10(9)/l]; 95% CI, -1.54 to -0.16; P = 0.02) and neutrophils (WMD, -1.57 [x10(9)/l]; 95% CI, -2.6 to -0.54; P = 0.003), greater counts of lymphocytes (WMD, 0.29 [x10(9)/l]; 95% CI, 0.22-0.36; P <0.001) and platelets (WMD, 19.05 [x10(9)/l]; 95% CI, 3.04-35.06; P = 0.02), and a lower neutrophil-to-lymphocyte (NLR) ratio (WMD, -2.48; 95% CI, - 3.81 to -1.15; P <0.001). There was no difference in the monocyte count (WMD, 0.01 [x10(9)/l]; 95% CI, -0.01 to 0.03; P = 0.029) between these 2 groups. Sensitivity analysis and meta-analysis based on standard mean difference did not change the conclusions regarding neutrophils, lymphocytes, and NLR, but yielded inconsistent results for white blood cells and platelets. CONCLUSIONS Patients with severe COVID-19 had a greater neutrophil count, a higher NLR, and a lower lymphocyte count than those with nonsevere COVID-19. Evaluation of these markers might help clinicians to monitor and predict the severity and prognosis of COVID-19.This publication has 20 references indexed in Scilit:
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Laparoscopic versus open gastrectomy for gastric cancerWorld Journal of Surgical Oncology, 2020
- Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptomsJournal of Clinical Laboratory Analysis, 2020
- Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: A meta-analysisThe International Journal of Biological Markers, 2019
- Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infectionInternational Immunopharmacology, 2017
- Neutrophil‐to‐lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infectionJournal of Gastroenterology and Hepatology, 2016
- Neutrophil in viral infections, friend or foe?Virus Research, 2013
- Contribution of Neutrophils to Acute Lung InjuryMolecular Medicine, 2010
- The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of miceRespiratory Research, 2008
- Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in MiceJournal of Virology, 2005